Stereotaxis, Inc.
AMEX:STXSMedical - Instruments & Supplies
+$0.05 today
- Market cap
- $94.80M
- Beta
- 1.32
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.22
Volume 0.90M
Average 0.39M
STXS Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Stereotaxis, Inc.AMEX: STXS
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow turns negative
Q1 FY2026 investing cash flow was -$79K, compared with $0 a year earlier. Trailing-twelve-month investing cash flow was -$172K. Over 3 fiscal years it compounded at -83.9% a year.
Context
- Investing cash flow amounted to 0.3% of revenue in FY2025, unchanged from a year earlier.
- Investing cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly investing cash flow holds near -$79K or moves back toward the trailing-twelve-month quarterly average of -$43K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (93K) USD
- Year-over-year change
- -225.7%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (93K) | -225.7% |
| FY2024 | 2024-12-31 | 74K | -99.6% |
| FY2023 | 2023-12-31 | 19.77M | +189.5% |
| FY2022 | 2022-12-31 | (22.09M) | -1481.5% |
| FY2021 | 2021-12-31 | (1.4M) | — |
Investing Cash Flow vs competitors
How STXS compares with its peers on the latest reported figures
- STXS's LTM Mar 2026 investing cash flow of $172K is the 4th largest of the 5 companies compared; the peer median is $1.63M.
- Its year-over-year change of -332.4% is the lowest of 5, against a peer median of +97.6%.
- Investing cash flow amounts to 0.6% of revenue for STXS, versus a peer median of 3.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $42.56M | +93.4% | +166.2% | 40530.5% | |
| LTM Mar 2026 | $2.84M | +101.9% | — | 5.9% | |
| LTM Mar 2026 | $412K | -106.3% | — | 0.4% | |
| LTM Mar 2026 | $172K | -332.4% | -83.9% | 0.6% | |
| LTM Mar 2026 | $153K | +133.4% | — | 0.4% | |
| Peer median (excluding STXS) | $1.63M | +97.6% | +166.2% | 3.1% | |
Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Depreciation & Amortization | 106K | 429K | 595K | 969K | 1.56M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 9.36M | 10.58M | 10.62M | 10.26M | 9.85M |
| Change in Working Capital | 135K | (1.1M) | 612K | 2.51M | (5.62M) |
| Accounts Receivables | (1.89M) | 316K | 1.27M | 691K | (2.02M) |
| Inventory | (1.14M) | (2.91M) | (550K) | 677K | (1.24M) |
| Accounts Payables | 1.43M | (169K) | 218K | 758K | (880K) |
| Other Working Capital | 1.73M | 1.66M | (324K) | 379K | (1.48M) |
| Other Non-Cash Items | (1.83M) | (25K) | (256K) | 1.81M | 2.17M |
| Operating Cash Flow | (2.95M) | (8.42M) | (9.14M) | (8.5M) | (13.69M) |
| Capital Expenditures | (1.4M) | (2.38M) | (366K) | (34K) | (93K) |
| Acquisitions (Net) | 0 | 0 | 0 | 108K | 0 |
| Purchases of Investments | 0 | (19.72M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 20.13M | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.4M) | (22.09M) | 19.77M | 74K | (93K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 547K | 220K | 81K | 297K | 14.76M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 547K | 220K | 81K | 297K | 14.76M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (3.8M) | (30.29M) | 10.71M | (8.13M) | 985K |
| Free Cash Flow | (4.34M) | (10.79M) | (9.51M) | (8.53M) | (13.78M) |
Stereotaxis, Inc.
AMEX:STXS
Intrinsic Alpha fair value
Locked
Current Price
$0.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.